BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15978095)

  • 1. Effects of plasminogen activator inhibitor-1 on ischemic brain injury in permanent and thrombotic middle cerebral artery occlusion models in mice.
    Nagai N; Suzuki Y; Van Hoef B; Lijnen HR; Collen D
    J Thromb Haemost; 2005 Jul; 3(7):1379-84. PubMed ID: 15978095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator inhibitor-1 contributes to the deleterious effect of obesity on the outcome of thrombotic ischemic stroke in mice.
    Nagai N; Van Hoef B; Lijnen HR
    J Thromb Haemost; 2007 Aug; 5(8):1726-31. PubMed ID: 17596132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice.
    Nagai N; De Mol M; Lijnen HR; Carmeliet P; Collen D
    Circulation; 1999 May; 99(18):2440-4. PubMed ID: 10318667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous plasminogen activator expression after embolic focal cerebral ischemia in mice.
    Ahn MY; Zhang ZG; Tsang W; Chopp M
    Brain Res; 1999 Aug; 837(1-2):169-76. PubMed ID: 10433999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice.
    Chen TY; Lee MY; Chen HY; Kuo YL; Lin SC; Wu TS; Lee EJ
    J Pineal Res; 2006 Apr; 40(3):242-50. PubMed ID: 16499561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats.
    Murakami K; Suzuki M; Suzuki N; Hamajo K; Tsukamoto T; Shimojo M
    Brain Res; 2013 Aug; 1526():84-93. PubMed ID: 23791950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vepoloxamer Enhances Fibrinolysis of tPA (Tissue-Type Plasminogen Activator) on Acute Ischemic Stroke.
    Wang C; Huang R; Li C; Lu M; Emanuele M; Zhang ZG; Chopp M; Zhang L
    Stroke; 2019 Dec; 50(12):3600-3608. PubMed ID: 31587657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 gene polymorphisms on tissue-type plasminogen activator-induced recanalization in ischemic stroke patients.
    Fernandez-Cadenas I; Alvarez-Sabin J; Ribo M; Rubiera M; Mendioroz M; Molina CA; Rosell A; Montaner J
    J Thromb Haemost; 2007 Sep; 5(9):1862-8. PubMed ID: 17723126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAI-1 but Not PAI-2 Gene Deficiency Attenuates Ischemic Brain Injury After Experimental Stroke.
    Griemert EV; Recarte Pelz K; Engelhard K; Schäfer MK; Thal SC
    Transl Stroke Res; 2019 Aug; 10(4):372-380. PubMed ID: 29978354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic platelet accumulation at the site of the occluded middle cerebral artery and in downstream microvessels is associated with loss of microvascular integrity after embolic middle cerebral artery occlusion.
    Zhang ZG; Zhang L; Tsang W; Goussev A; Powers C; Ho KL; Morris D; Smyth SS; Coller BS; Chopp M
    Brain Res; 2001 Sep; 912(2):181-94. PubMed ID: 11532435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Thrombin-Activatable Fibrinolysis Inhibitor and Plasminogen Activator Inhibitor-1 Reduces Ischemic Brain Damage in Mice.
    Denorme F; Wyseure T; Peeters M; Vandeputte N; Gils A; Deckmyn H; Vanhoorelbeke K; Declerck PJ; De Meyer SF
    Stroke; 2016 Sep; 47(9):2419-22. PubMed ID: 27470988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid differential endogenous plasminogen activator expression after acute middle cerebral artery occlusion.
    Hosomi N; Lucero J; Heo JH; Koziol JA; Copeland BR; del Zoppo GJ
    Stroke; 2001 Jun; 32(6):1341-8. PubMed ID: 11387497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
    Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
    J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia.
    Yang G; Chan PH; Chen J; Carlson E; Chen SF; Weinstein P; Epstein CJ; Kamii H
    Stroke; 1994 Jan; 25(1):165-70. PubMed ID: 8266365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of acupoint-embedment of medicated-thread and acupoint-injection on expression of cortical urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in rats with cerebral ischemia-reperfusion injury].
    Kong LH; Ye YW; Zhou H; Zhou HJ; Du YJ; Cui CX
    Zhen Ci Yan Jiu; 2010 Dec; 35(6):409-14. PubMed ID: 21375013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated transfer of tissue-type plasminogen activator augments thrombolysis in tissue-type plasminogen activator-deficient and plasminogen activator inhibitor-1-overexpressing mice.
    Carmeliet P; Stassen JM; Van Vlaenderen I; Meidell RS; Collen D; Gerard RD
    Blood; 1997 Aug; 90(4):1527-34. PubMed ID: 9269770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroserpin, a neuroprotective factor in focal ischemic stroke.
    Cinelli P; Madani R; Tsuzuki N; Vallet P; Arras M; Zhao CN; Osterwalder T; Rülicke T; Sonderegger P
    Mol Cell Neurosci; 2001 Nov; 18(5):443-57. PubMed ID: 11922137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of basic fibroblast growth factor on experimental focal ischemia studied by diffusion-weighted and perfusion imaging.
    Tatlisumak T; Takano K; Carano RA; Fisher M
    Stroke; 1996 Dec; 27(12):2292-7; discussion 2298. PubMed ID: 8969796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reductions in mRNA of the neuroprotective agent, neuroserpin, after cerebral ischemia/reperfusion in diabetic rats.
    Liang W; Chuan-Zhen L; Qiang D; Jian Q; Hui-Min R; Bao-Guo X
    Brain Res; 2004 Jul; 1015(1-2):175-80. PubMed ID: 15223382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular release of plasminogen activator inhibitor-1 impairs fibrinolysis during acute arterial thrombosis in mice.
    Kawasaki T; Dewerchin M; Lijnen HR; Vermylen J; Hoylaerts MF
    Blood; 2000 Jul; 96(1):153-60. PubMed ID: 10891445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.